140 related articles for article (PubMed ID: 1563205)
1. Biotechnology and therapeutics: expensive treatments and limited resources. A view from the hospital.
Meyer BR
Clin Pharmacol Ther; 1992 Apr; 51(4):359-65. PubMed ID: 1563205
[No Abstract] [Full Text] [Related]
2. The pharmacoeconomics of high-cost biotechnology products.
Dana WJ; Farthing K
Pharm Pract Manag Q; 1998 Jul; 18(2):23-31. PubMed ID: 10185236
[TBL] [Abstract][Full Text] [Related]
3. Reengineering the retail/ambulatory pharmacy for provision of biotechnology pharmaceutical services.
Schneider PJ
Pharm Pract Manag Q; 1998 Jul; 18(2):32-6. PubMed ID: 10185237
[TBL] [Abstract][Full Text] [Related]
4. SOZO--a Euro-Japanese biotechnology conference.
Veryard C
IDrugs; 2005 Jul; 8(7):560-2. PubMed ID: 15973563
[No Abstract] [Full Text] [Related]
5. The evolution of biotech.
Berg C; Nassr R; Pang K
Nat Rev Drug Discov; 2002 Nov; 1(11):845-6. PubMed ID: 12425308
[No Abstract] [Full Text] [Related]
6. BioChannel 2004. 2 December 2004, Ashford, UK.
Worker C
IDrugs; 2005 Feb; 8(2):115-7. PubMed ID: 15696411
[No Abstract] [Full Text] [Related]
7. The gold rush.
Bryant A
Newsweek; 2000 Apr; 135(15):64-7. PubMed ID: 10847895
[No Abstract] [Full Text] [Related]
8. Prescription for an ailing pharmaceutical industry.
Demain AL
Nat Biotechnol; 2002 Apr; 20(4):331. PubMed ID: 11923826
[No Abstract] [Full Text] [Related]
9. Deal watch: Trends in platform technology deal-making.
Walker J; Jacob J
Nat Rev Drug Discov; 2009 Dec; 8(12):923. PubMed ID: 19949395
[No Abstract] [Full Text] [Related]
10. Mainstreaming microfluidics: diffusing microfluidics technology in the marketplace.
Braun D
Pharmacogenomics; 2003 Jul; 4(4):375-8. PubMed ID: 12831316
[No Abstract] [Full Text] [Related]
11. Biotechnology partnerships--medicine for an ailing industry?
DeLamarter J
Nat Biotechnol; 2003 Aug; 21(8):847-8. PubMed ID: 12894192
[No Abstract] [Full Text] [Related]
12. siRNAs: applications in functional genomics and potential as therapeutics.
Dorsett Y; Tuschl T
Nat Rev Drug Discov; 2004 Apr; 3(4):318-29. PubMed ID: 15060527
[No Abstract] [Full Text] [Related]
13. Vaccines-all things considered. Part II. 2-3 December 2004, San Francisco, CA, USA.
Rosenthal KS
IDrugs; 2005 Feb; 8(2):110-1. PubMed ID: 15696409
[No Abstract] [Full Text] [Related]
14. Rediscovering plant-based drugs.
Littleton J; Falcone D; Davies HM
Nat Biotechnol; 2003 Aug; 21(8):843-4. PubMed ID: 12894188
[No Abstract] [Full Text] [Related]
15. Sandoz: Swiss corporation moving towards global image.
Woods D
CMAJ; 1987 Mar; 136(5):528-34. PubMed ID: 3102031
[No Abstract] [Full Text] [Related]
16. Improving access to medicines for neglected tropical diseases in developing countries: lessons from three emerging economies.
Holt F; Gillam SJ; Ngondi JM
PLoS Negl Trop Dis; 2012; 6(2):e1390. PubMed ID: 22389728
[No Abstract] [Full Text] [Related]
17. Packaging challenges: the solution is just beyond the border.
Merritt J
Med Device Technol; 2003 Mar; 14(2):12-5. PubMed ID: 12698691
[TBL] [Abstract][Full Text] [Related]
18. Biotech on the brink.
Taylor KS
Hosp Health Netw; 1993 Sep; 67(17):36, 38. PubMed ID: 8353563
[No Abstract] [Full Text] [Related]
19. The impact of computing technology on pharmaceutical and biotech research.
Owen J
IDrugs; 2005 Oct; 8(10):834-7. PubMed ID: 16254804
[TBL] [Abstract][Full Text] [Related]
20. Cost effectiveness and biotechnology.
Randerson DH
Australas Biotechnol; 1992 Dec; 2(6):361-4. PubMed ID: 1283086
[No Abstract] [Full Text] [Related]
[Next] [New Search]
